Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s10741-008-9129-3, but it redirected us to https://link.springer.com/article/10.1007/s10741-008-9129-3. The analysis below is for the second page.

Title[redir]:
Relaxin, a pleiotropic vasodilator for the treatment of heart failure | Heart Failure Reviews
Description:
Relaxin is a naturally occurring peptide hormone that plays a central role in the hemodynamic and renovascular adaptive changes that occur during pregnancy. Triggering similar changes could potentially be beneficial in the treatment of patients with heart failure. The effects of relaxin include the production of nitric oxide, inhibition of endothelin, inhibition of angiotensin II, production of VEGF, and production of matrix metalloproteinases. These effects lead to systemic and renal vasodilation, increased arterial compliance, and other vascular changes. The recognition of this has led to the study of relaxin for the treatment of heart failure. An initial pilot study has shown favorable hemodynamic effects in patients with heart failure, including reduction in ventricular filling pressures and increased cardiac output. The ongoing RELAX-AHF clinical program is designed to evaluate the effects of relaxin on the symptoms and outcomes in a large group of patients admitted to hospital for acute heart failure. This review will summarize both the biology of relaxin and the data supporting its potential efficacy in human heart failure.

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 96,105,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

relaxin, heart, failure, renal, google, scholar, article, pubmed, cas, patients, acute, vascular, vasodilation, human, effects, rats, systemic, function, pregnancy, hemodynamic, endothelin, arterial, subjects, study, cardiac, blood, pressure, receptor, increase, data, treatment, peptide, compliance, fig, increases, dose, clinical, receptors, gfr, doses, conrad, lgr, role, production, increased, cells, effect, infusion, full, hormone,

Topics {✒️}

l-arginine-nitric oxide pathway renin-angiotensin-aldosterone system article download pdf favorable benefit-risk profile g-protein coupled receptor mitogen-activated protein kinase 10–100 μg/kg/day appeared 240–960 μg/kg/day tended relaxin-stimulated tyrosine phosphorylation 1000 pg/ml levels attained counter-regulatory neurohormonal mechanisms open-label study pharmacodynamic dose-response parameters receptor closely related mediate maternal adjustments danielson la relaxin-induced renal vasodilation acute heart failure acute heart failure privacy choices/manage cookies diastolic blood pressure specific relaxin-binding cells human heart failure full access acute vascular failure relaxin-mediated renal vasodilation renal blood flow reduced myogenic reactivity human renal fibroblasts human dermal fibroblasts pre-relax-ahf ventricular filling pressures vasodilator peptide secreted sympathetic nervous system human endometrial cells worsening heart failure chronic heart failure recombinant human relaxin prior human testing hisaw fl jr systolic blood pressure elevated blood pressure heart failure studies guinea pigs injected 6–200 μg/kg/day 960 μg/kg/day μg/kg/day 6-kda peptide made relaxin stimulates expression type natriuretic peptide

Questions {❓}

  • Cotter G, Felker GM et al (2008) The pathophysiology of acute heart failure—Is it all about fluid accumulation?
  • Fisher C, MacLean M et al (2002) Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?
  • Milo-Cotter O, Adams KF et al (2007) Acute heart failure associated with high admission blood pressure—A distinct vascular disorder?
  • Schrier RW (2006) Role of diminished renal function in cardiovascular mortality: marker of pathogenetic factor?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Relaxin, a pleiotropic vasodilator for the treatment of heart failure
         description:Relaxin is a naturally occurring peptide hormone that plays a central role in the hemodynamic and renovascular adaptive changes that occur during pregnancy. Triggering similar changes could potentially be beneficial in the treatment of patients with heart failure. The effects of relaxin include the production of nitric oxide, inhibition of endothelin, inhibition of angiotensin II, production of VEGF, and production of matrix metalloproteinases. These effects lead to systemic and renal vasodilation, increased arterial compliance, and other vascular changes. The recognition of this has led to the study of relaxin for the treatment of heart failure. An initial pilot study has shown favorable hemodynamic effects in patients with heart failure, including reduction in ventricular filling pressures and increased cardiac output. The ongoing RELAX-AHF clinical program is designed to evaluate the effects of relaxin on the symptoms and outcomes in a large group of patients admitted to hospital for acute heart failure. This review will summarize both the biology of relaxin and the data supporting its potential efficacy in human heart failure.
         datePublished:2008-12-20T00:00:00Z
         dateModified:2008-12-20T00:00:00Z
         pageStart:321
         pageEnd:329
         license:https://creativecommons.org/licenses/by-nc/2.0
         sameAs:https://doi.org/10.1007/s10741-008-9129-3
         keywords:
            Relaxin
            Acute heart failure
            Vasodilator
            Hemodynamic
            Renovascular
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig7_HTML.gif
         isPartOf:
            name:Heart Failure Reviews
            issn:
               1573-7322
               1382-4147
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sam L. Teichman
               affiliation:
                     name:Corthera Inc.
                     address:
                        name:Corthera Inc., San Mateo, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Elaine Unemori
               affiliation:
                     name:Corthera Inc.
                     address:
                        name:Corthera Inc., San Mateo, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Dschietzig
               affiliation:
                     name:Charité Hospital – University Medicine
                     address:
                        name:Department of Cardiology and Angiology, Charité Hospital – University Medicine, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kirk Conrad
               affiliation:
                     name:University of Florida College of Medicine
                     address:
                        name:Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adriaan A. Voors
               affiliation:
                     name:University Medical Center Groningen
                     address:
                        name:Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Groningen, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John R. Teerlink
               affiliation:
                     name:University of California
                     address:
                        name:Section of Cardiology, Veterans Affairs Medical Center, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Michael Felker
               affiliation:
                     name:Duke Clinical Research Institute
                     address:
                        name:Department of Cardiology, Duke Clinical Research Institute, Durham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marco Metra
               affiliation:
                     name:University of Brescia
                     address:
                        name:Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gad Cotter
               affiliation:
                     name:Momentum Research Inc.
                     address:
                        name:Momentum Research Inc., Durham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Relaxin, a pleiotropic vasodilator for the treatment of heart failure
      description:Relaxin is a naturally occurring peptide hormone that plays a central role in the hemodynamic and renovascular adaptive changes that occur during pregnancy. Triggering similar changes could potentially be beneficial in the treatment of patients with heart failure. The effects of relaxin include the production of nitric oxide, inhibition of endothelin, inhibition of angiotensin II, production of VEGF, and production of matrix metalloproteinases. These effects lead to systemic and renal vasodilation, increased arterial compliance, and other vascular changes. The recognition of this has led to the study of relaxin for the treatment of heart failure. An initial pilot study has shown favorable hemodynamic effects in patients with heart failure, including reduction in ventricular filling pressures and increased cardiac output. The ongoing RELAX-AHF clinical program is designed to evaluate the effects of relaxin on the symptoms and outcomes in a large group of patients admitted to hospital for acute heart failure. This review will summarize both the biology of relaxin and the data supporting its potential efficacy in human heart failure.
      datePublished:2008-12-20T00:00:00Z
      dateModified:2008-12-20T00:00:00Z
      pageStart:321
      pageEnd:329
      license:https://creativecommons.org/licenses/by-nc/2.0
      sameAs:https://doi.org/10.1007/s10741-008-9129-3
      keywords:
         Relaxin
         Acute heart failure
         Vasodilator
         Hemodynamic
         Renovascular
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10741-008-9129-3/MediaObjects/10741_2008_9129_Fig7_HTML.gif
      isPartOf:
         name:Heart Failure Reviews
         issn:
            1573-7322
            1382-4147
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sam L. Teichman
            affiliation:
                  name:Corthera Inc.
                  address:
                     name:Corthera Inc., San Mateo, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Elaine Unemori
            affiliation:
                  name:Corthera Inc.
                  address:
                     name:Corthera Inc., San Mateo, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Dschietzig
            affiliation:
                  name:Charité Hospital – University Medicine
                  address:
                     name:Department of Cardiology and Angiology, Charité Hospital – University Medicine, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kirk Conrad
            affiliation:
                  name:University of Florida College of Medicine
                  address:
                     name:Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adriaan A. Voors
            affiliation:
                  name:University Medical Center Groningen
                  address:
                     name:Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Groningen, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John R. Teerlink
            affiliation:
                  name:University of California
                  address:
                     name:Section of Cardiology, Veterans Affairs Medical Center, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Michael Felker
            affiliation:
                  name:Duke Clinical Research Institute
                  address:
                     name:Department of Cardiology, Duke Clinical Research Institute, Durham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marco Metra
            affiliation:
                  name:University of Brescia
                  address:
                     name:Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gad Cotter
            affiliation:
                  name:Momentum Research Inc.
                  address:
                     name:Momentum Research Inc., Durham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Heart Failure Reviews
      issn:
         1573-7322
         1382-4147
      volumeNumber:14
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Corthera Inc.
      address:
         name:Corthera Inc., San Mateo, USA
         type:PostalAddress
      name:Corthera Inc.
      address:
         name:Corthera Inc., San Mateo, USA
         type:PostalAddress
      name:Charité Hospital – University Medicine
      address:
         name:Department of Cardiology and Angiology, Charité Hospital – University Medicine, Berlin, Germany
         type:PostalAddress
      name:University of Florida College of Medicine
      address:
         name:Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, USA
         type:PostalAddress
      name:University Medical Center Groningen
      address:
         name:Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Groningen, The Netherlands
         type:PostalAddress
      name:University of California
      address:
         name:Section of Cardiology, Veterans Affairs Medical Center, University of California, San Francisco, USA
         type:PostalAddress
      name:Duke Clinical Research Institute
      address:
         name:Department of Cardiology, Duke Clinical Research Institute, Durham, USA
         type:PostalAddress
      name:University of Brescia
      address:
         name:Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy
         type:PostalAddress
      name:Momentum Research Inc.
      address:
         name:Momentum Research Inc., Durham, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sam L. Teichman
      affiliation:
            name:Corthera Inc.
            address:
               name:Corthera Inc., San Mateo, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Elaine Unemori
      affiliation:
            name:Corthera Inc.
            address:
               name:Corthera Inc., San Mateo, USA
               type:PostalAddress
            type:Organization
      name:Thomas Dschietzig
      affiliation:
            name:Charité Hospital – University Medicine
            address:
               name:Department of Cardiology and Angiology, Charité Hospital – University Medicine, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Kirk Conrad
      affiliation:
            name:University of Florida College of Medicine
            address:
               name:Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, USA
               type:PostalAddress
            type:Organization
      name:Adriaan A. Voors
      affiliation:
            name:University Medical Center Groningen
            address:
               name:Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Groningen, The Netherlands
               type:PostalAddress
            type:Organization
      name:John R. Teerlink
      affiliation:
            name:University of California
            address:
               name:Section of Cardiology, Veterans Affairs Medical Center, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:G. Michael Felker
      affiliation:
            name:Duke Clinical Research Institute
            address:
               name:Department of Cardiology, Duke Clinical Research Institute, Durham, USA
               type:PostalAddress
            type:Organization
      name:Marco Metra
      affiliation:
            name:University of Brescia
            address:
               name:Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy
               type:PostalAddress
            type:Organization
      name:Gad Cotter
      affiliation:
            name:Momentum Research Inc.
            address:
               name:Momentum Research Inc., Durham, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Corthera Inc., San Mateo, USA
      name:Corthera Inc., San Mateo, USA
      name:Department of Cardiology and Angiology, Charité Hospital – University Medicine, Berlin, Germany
      name:Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, USA
      name:Department of Cardiology, Thoraxcenter, University Medical Center Groningen, Groningen, The Netherlands
      name:Section of Cardiology, Veterans Affairs Medical Center, University of California, San Francisco, USA
      name:Department of Cardiology, Duke Clinical Research Institute, Durham, USA
      name:Section of Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia, Brescia, Italy
      name:Momentum Research Inc., Durham, USA

External Links {🔗}(327)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

5.42s.